Publications by authors named "Roberta Mussinelli"

Claim this Profile
L
Long-term follow-up with magnetic resonance neurography in a patient with hereditary transthyretin amyloidosis treated with inotersen.
Roberto Gasparotti, Alessandro Salvalaggio, Roberta Mussinelli, Alessandro Lozza, Laura Obici

J Neurol Sci· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Validated Staging System for Light Chain (AL) Amyloidosis With Stage IIIC Defining Ultra-Poor Risk: AL International Staging System.
Jahanzaib Khwaja, Amy A Kirkwood, Paolo Milani, Binoy Yohannan, Foteini Theodorakakou, Roberta Mussinelli

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Change in prevalence of ATTR variants in Italy: results from a national survey.
Carlo Fumagalli, Simone Longhi, Alberto Aimo, Alessia Argirò, Alessandro Barilaro, Roberta Mussinelli

Eur Heart J Qual Care Clin Outcomes· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Left ventriculo-arterial coupling in a contemporary cohort of patients with wild-type transthyretin cardiac amyloidosis treated with tafamidis.
Giuseppe Damiano Sanna, Valeria Anna Di Simone, Paolo Milani, Alessandro Fogliani, Roberta Mussinelli

Clin Res Cardiol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurohormonal therapies at baseline and follow-up and survival in wild-type transthyretin cardiac amyloidosis.
Alberto Aimo, Paolo Milani, Giacomo Tini, Giuseppe Vergaro, Marco Basset, Roberta Mussinelli

J Cardiovasc Med (Hagerstown)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Performance of the New Free Light Chain Ratio in Systemic Amyloidosis.
Paolo Milani, Giuseppe Damiano Sanna, Claudia Bellofiore, Mario Nuvolone, Marco Basset, Roberta Mussinelli

JACC CardioOncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Sensitivity Cardiac Troponin I for Risk Stratification in Wild-Type Transthyretin Amyloid Cardiomyopathy.
Laura De Michieli, Giulio Sinigiani, Gianluigi Guida, Giulia Saturi, Giuseppe Sena, Roberta Mussinelli

Circ Heart Fail· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab-based regimens versus CyBorD in newly diagnosed patients with AL amyloidosis and IIIb cardiac stage: A matched case-control study.
Claudia Bellofiore, Marco Basset, Giuseppe Damiano Sanna, Andrea Foli, Roberta Mussinelli

Hemasphere· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND study.
Giacomo Tini, Beatrice Musumeci, Paolo Milani, Mattia Zampieri, Angelo Giuseppe Caponetti, Roberta Mussinelli

ESC Heart Fail· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Long-term treatment of hereditary transthyretin amyloidosis with patisiran: multicentre, real-world experience in Italy.
Luca Gentile, Anna Mazzeo, Chiara Briani, Silvia Casagrande, Marcella De Luca, Roberta Mussinelli

Neurol Sci· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Early Death in Patients With Wild-Type Transthyretin Cardiac Amyloidosis.
Paolo Milani, Giuseppe Damiano Sanna, Roberta Mussinelli, Marco Basset, Gianluigi Guida

J Am Heart Assoc· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term treatment of hereditary transthyretin amyloidosis with patisiran: multicentre, real-world experience in Italy.
Luca Gentile, Anna Mazzeo, Chiara Briani, Silvia Casagrande, Marcella De Luca, Roberta Mussinelli

Neurol Sci· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delayed identification of monoclonal protein is associated with early death in isolated cardiac AL amyloidosis.
Paolo Milani, Francesca Fabris, Roberta Mussinelli, Giuseppe Damiano Sanna, Marco Basset

Amyloid· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A real-life study of daratumumab combinations in newly diagnosed patients with light chain (AL) amyloidosis.
Claudia Bellofiore, Pietro Benvenuti, Roberto Mina, Marco Basset, Andrea Foli, Roberta Mussinelli

Hematol Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of Staging Systems for AA Amyloidosis.
Marco Basset, Stefan O Schönland, Laura Obici, Janine Günther, Eloisa Riva, Roberta Mussinelli

J Am Soc Nephrol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electrocardiographic features and rhythm disorders in cardiac amyloidosis.
Nicolò Martini, Giulio Sinigiani, Laura De Michieli, Roberta Mussinelli, Martina Perazzolo Marra

Trends Cardiovasc Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Learning From Trials: Time to Look More Closely at the Kidneys in ATTR Amyloidosis?
Laura Obici, Roberta Mussinelli, Giovanni Palladini

JACC CardioOncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Echocardiographic findings in subjects with an amyloidogenic apolipoprotein A1 pathogenic variant.
Daniela Tomasoni, Alberto Aimo, Marianna Adamo, Matilde Nardi, Carlo Mario Lombardi, Roberta Mussinelli

Amyloid· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network study.
Giacomo Tini, Paolo Milani, Mattia Zampieri, Angelo G Caponetti, Francesca Fabris, Roberta Mussinelli

Eur J Heart Fail· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Muscle quantitative MRI as a novel biomarker in hereditary transthyretin amyloidosis with polyneuropathy: a cross-sectional study.
Elisa Vegezzi, Andrea Cortese, Niels Bergsland, Roberta Mussinelli, Matteo Paoletti

J Neurol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms.
Esther Gonzalez-Lopez, Luis Escobar-Lopez, Laura Obici, Giulia Saturi, Mélanie Bezard, Roberta Mussinelli

JACC CardioOncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life experience with inotersen in hereditary transthyretin amyloidosis with late-onset phenotype: Data from an early-access program in Italy.
Marco Luigetti, Giovanni Antonini, Andrea Di Paolantonio, Luca Gentile, Marina Grandis, Roberta Mussinelli

Eur J Neurol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and Emerging Therapies for Hereditary Transthyretin Amyloidosis: Strides Towards a Brighter Future.
Laura Obici, Roberta Mussinelli

Neurotherapeutics· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence of disease flares is associated with an inadequate colchicine dose in familial Mediterranean fever: A national multicenter longitudinal study.
Marta Bustaffa, Francesca Mazza, Diana Sutera, Maria Domenica Carrabba, Maria Alessio, Roberta Mussinelli

J Allergy Clin Immunol Pract· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering.
Augusto Di Castelnuovo, Alessandro Gialluisi, Andrea Antinori, Nausicaa Berselli, Lorenzo Blandi, Roberta Mussinelli

J Healthc Eng· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis